CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 119 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -33.3% | 295 | -0.3% | 0.01% | -28.6% |
| Q2 2023 | $9 | +28.6% | 296 | -0.7% | 0.01% | +16.7% |
| Q1 2023 | $7 | -65.0% | 298 | -50.5% | 0.01% | -25.0% |
| Q4 2022 | $20 | -99.8% | 602 | +99.3% | 0.01% | 0.0% |
| Q3 2022 | $9,000 | +12.5% | 302 | -1.0% | 0.01% | +33.3% |
| Q2 2022 | $8,000 | -27.3% | 305 | -1.3% | 0.01% | -14.3% |
| Q1 2022 | $11,000 | +83.3% | 309 | +67.0% | 0.01% | -12.5% |
| Q4 2021 | $6,000 | – | 185 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |